| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2003 | Clinical application of 20 MHz endosonography and anti-Helicobacter pylori immunoblots to predict regression of low-grade gastric MALtoma by H. pylori eradication | Sheu B.-S.; Shiesh S.-C.; Wang, Jin-Town ; Yang H.-B.; Lin S.-T.; Wu J.-J. | Helicobacter | 11 | 10 | |
| 2016 | Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial | JYH-MING LIOU ; YU-JEN FANG ; CHIEH-CHANG CHEN ; Bair M.-J.; Chang C.-Y.; YI-CHIA LEE ; Chen M.-J.; CHIEH-CHANG CHEN ; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; CHIA-TUNG SHUN ; WEN-FENG HSU ; Hu W.-H.; YEN-NIEN CHEN ; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; MING-SHIANG WU ; Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | The Lancet | 96 | 92 | |
| 2015 | Consensus of gastroesophageal reflux disease in Taiwan with endoscopy-based approach covered by National Health Insurance | Sheu B.-S.; Chiu C.-T.; YI-CHIA LEE ; Chang C.-Y.; Wu D.-C.; JYH-MING LIOU ; MING-SHIANG WU ; Chang W.-L.; Wu C.-Y.; Lin J.-T. | Advances in Digestive Medicine | 4 | 0 | |
| 2014 | Consensus on control of risky nonvariceal upper gastrointestinal bleeding in Taiwan with National Health Insurance | Sheu B.-S.; Wu C.-Y.; MING-SHIANG WU ; Chiu C.-T.; Lin C.-C.; Hsu P.-I.; Cheng H.-C.; Lee T.-Y.; HSIU-PO WANG ; Lin J.-T. | BioMed Research International | 8 | 8 | |
| 2017 | Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale | Sheu B.-S.; MING-SHIANG WU ; Chiu C.-T.; Lo J.-C.; Wu D.-C.; JYH-MING LIOU ; Wu C.-Y.; Cheng H.-C.; YI-CHIA LEE ; Hsu P.-I.; Chang C.-C.; Chang W.-L.; Lin J.-T. | Helicobacter | 51 | 51 | |
| 2019 | H. pylori isolates with amino acid sequence polymorphisms as presence of both HtrA-L171 & CagL-Y58/E59 increase the risk of gastric cancer | Yeh Y.-C.; Kuo H.-Y.; Chang W.-L.; Yang H.-B.; Lu C.-C.; Cheng H.-C.; MING-SHIANG WU ; Sheu B.-S. | Journal of Biomedical Science | 5 | 6 | |
| 2018 | The implementation of the consensus on the management of Helicobacter pylori and barriers to consensus | Cheng H.-C.; JYH-MING LIOU ; Luo J.-C.; Chiu C.-T.; MING-SHIANG WU ; YI-CHIA LEE ; Wu C.-Y.; Wu D.-C.; Hsu P.-I.; Chang C.-C.; Chang W.-L.; Lin J.-T.; Sheu B.-S. | Helicobacter | 1 | 1 | |
| 2005 | Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma | Chen L.-T.; Lin J.-T.; Tai J.J.; Chen G.-H.; Yeh H.-Z.; Yang S.-S.; HSIU-PO WANG ; SUNG-HSIN KUO ; Sheu B.-S.; Jan C.-M.; Wang W.-M.; Wang T.-E.; Wu C.-W.; Chen C.-L.; Su I.-J.; Whang-Peng J.; ANN-LII CHENG | Journal of the National Cancer Institute | 166 | 132 | |
| 2018 | Nutrition therapy in esophageal cancer—Consensus statement of the Gastroenterological Society of Taiwan | Chen M.-J.; Wu I.-C.; Chen Y.-J.; Wang T.-E.; Chang Y.-F.; Yang C.-L.; Huang W.-C.; Chang W.-K.; Sheu B.-S.; MING-SHIANG WU ; Lin J.-T.; Chu C.-H. | Diseases of the Esophagus | 18 | 18 | |
| 2020 | Phase 4 study in patients from Asia with gastroesophageal reflux disease treated with dexlansoprazole | Wu J.C.Y.; Sheu B.-S.; MING-SHIANG WU ; Lee Y.C.; Choi M.-G. | Journal of Neurogastroenterology and Motility | 0 | 0 | |
| 2015 | The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors - A nationwide study | JYH-MING LIOU ; Chang C.-Y.; Chen M.-J.; CHIEH-CHANG CHEN ; YU-JEN FANG ; Lee J.-Y.; Wu J.-Y.; Luo J.-C.; Liou T.-C.; Chang W.-H.; Tseng C.-H.; Wu C.-Y.; Yang T.-H.; Chang C.-C.; HSIU-PO WANG ; Sheu B.-S.; Lin J.-T.; Bair M.-J.; MING-SHIANG WU ; Tai C.-M.; Lee C.-T.; Wang W.-L.; YI-CHIA LEE ; Wang Y.-C.; Taiwan Gastrointestinal Disease; Helicobacter Consortium | PLoS ONE | 62 | 63 | |
| 2020 | Screening and eradication of Helicobacter pylori for gastric cancer prevention: The Taipei global consensus | JYH-MING LIOU ; Malfertheiner P.; YI-CHIA LEE ; Sheu B.-S.; Sugano K.; Cheng H.-C.; Yeoh K.-G.; Hsu P.-I.; Goh K.-L.; Mahachai V.; Gotoda T.; Chang W.-L.; Chen M.-J.; TSUNG-HSIEN CHIANG ; CHIEH-CHANG CHEN ; Wu C.-Y.; Leow A.H.-R.; Wu J.-Y.; Wu D.-C.; Hong T.-C.; Lu H.; Yamaoka Y.; Megraud F.; Chan F.K.L.; Sung J.J.Y.; Lin J.-T.; Graham D.Y.; MING-SHIANG WU ; El-Omar E.M. | Gut | 130 | 127 | |
| 2004 | Serological Responses of FldA and Small-Molecular-Weight Proteins of Helicobacter pylori: Correlation with the Presence of the Gastric MALT Tissue | Yang H.-B.; Sheu B.-S.; Wang, Jin-Town ; Lin S.-T.; Wu J.-J. | Helicobacter | 10 | 7 | |
| 2018 | Survey of the adherence to the consensus of gastroesophageal reflux disease before and after the implementation course | JYH-MING LIOU ; Sheu B.-S.; YI-CHIA LEE ; Cheng H.-C.; Chang W.-L.; Wu D.-C.; Hsu P.-I.; Wu C.-Y.; MING-SHIANG WU ; Chiu C.-T.; Lin J.-T. | Journal of the Formosan Medical Association | 1 | 2 |
